跳至主要内容
临床试验/NCT00135122
NCT00135122已完成3 期

Medication Overuse Headache: A Randomised Double Blind Study of Prednisolone or Placebo in Withdrawal Therapy (Phase 3), and a Randomised 1 Year Follow up by Neurologist or General Physician After Successful Withdrawal Therapy

Sorlandet Hospital HF1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2003年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
The primary endpoint was a calculated mean headache (MH), based on number of days with headache and mean intensity of headache during the first six days after withdrawal.

研究概览

简要总结

The purpose of this study is to determine whether prednisolone is more effective than placebo in the first six days after initiation of medication withdrawal therapy for a medication overuse headache. Another purpose is to study whether patients followed by a neurologist 1 year after withdrawal do better than patients followed by a general practitioner.

详细描述

Data published BoeMG,Mygland A,Salvesen R; Neurology 2007 Jul 3;69(1):26-31

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic daily headache and medication overuse fulfilling International Headache Society (IHS)-II criteria

排除标准

  • Pregnancy
  • Age under 18 and over 70 years
  • Major mental disorders

研究组 & 干预措施

2

Placebo Comparator

Placebo in six days

干预措施: prednisolone (Drug)

结局指标

主要结局

The primary endpoint was a calculated mean headache (MH), based on number of days with headache and mean intensity of headache during the first six days after withdrawal.

时间窗: 6 days

次要结局

  • number of days with zero or mild headache, days with moderate to strong headache, days without headache, Use of antiemetic drugs ,staying drug-free during the entire period.(1 month)

研究者

发起方
Sorlandet Hospital HF
申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验